2024 PARTNERS
Expertise Partner
CYTOO is a drug discovery biotech company specialized in muscle health disorders. CYTOO pioneered MyoScreenTM, an in vitro R&D platform that enables the testing of muscle therapies in standardized, primary patient derived skeletal muscle cells. Using innovative, image-based, high-throughput assays and quantitative functional assay, MyoScreen facilitates therapeutic discovery at all stages, from target identification to the development of functional potency assays. With over 50 R&D partnerships involving RNA and gene therapies, CYTOO is at the forefront of innovation. To better support CMC related activities, CYTOO is establishing a GMP environment set to be operational in 2025.
Innovation Partner
Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for assessing drug safety, efficacy, and potency.
Innovation Partner
Svar offers a unique combination of scientific expertise, high-quality products, strong services, and proprietary technology platforms. Our repertoire includes AAV potency assessments, enhancing our commitment to excellence. Renowned for iLite® technology and bespoke solutions, we guide clients through intricate challenges, fueling breakthroughs in drug development.
Exhibition Partner
Avance Biosciences is a leading CRO/CTL providing GLP & GMP-compliant assay development, assay validation, and sample testing services to support biological drug development and manufacturing activities world-wide. We work with many clients across multiple modalities for potency assay development, method transfer, validation and sample testing. In addition we can support long term stability studies with potency testing and compendial assay testing for pH, sterility, mycoplasma, endotoxin, appearance and others. Our platforms include flow cytometry, ELISA, MSD-ECLA, ddPCR, qPCR, NGS and cell-based assays.
Exhibition Partner
Stegmann Systems has been developing PLA for over 25 years, shaping it into the world's leading bioassay software. The software offers a broad range of functionalities and delivers an extensive array of biostatistical tools tailored to immunoassays, ELISA, and more. Of course, PLA is compliant software providing you with advanced methods in accordance with various pharmacopoeias, other guidelines, industry standards, and best practices. The software is utilized in 80 countries by more than 800 organizations and over 10,000 end-users, including all of the top 100 pharmaceutical companies.
Event Partner
Bio-Techne® empowers scientists and clinicians by providing high-quality reagents, analytical instruments, and precision diagnostics. Whether you’re at the cutting edge of academic research, translating discoveries to therapeutic leads, or requiring the highest level of diagnostic testing, you’ll find products and services that help lead you to better answers.
Media Partner
BioPharma Asia
BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information is always guaranteed to remain timely, informative, and unbiased.
